These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31214151)

  • 1. Heterogeneous Vancomycin-Intermediate
    Dai Y; Gao C; Chen L; Chang W; Yu W; Ma X; Li J
    Front Microbiol; 2019; 10():1222. PubMed ID: 31214151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VraSR has an important role in immune evasion of Staphylococcus aureus with low level vancomycin resistance.
    Gao C; Dai Y; Chang W; Fang C; Wang Z; Ma X
    Microbes Infect; 2019; 21(8-9):361-367. PubMed ID: 31009806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional profiling of the two-component regulatory system VraSR in Staphylococcus aureus with low-level vancomycin resistance.
    Chen H; Xiong Z; Liu K; Li S; Wang R; Wang X; Zhang Y; Wang H
    Int J Antimicrob Agents; 2016 May; 47(5):362-7. PubMed ID: 27084050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VraR Binding to the Promoter Region of
    Dai Y; Chang W; Zhao C; Peng J; Xu L; Lu H; Zhou S; Ma X
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28289032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evolution of vancomycin intermediate Staphylococcus aureus (VISA) and heterogenous-VISA.
    Howden BP; Peleg AY; Stinear TP
    Infect Genet Evol; 2014 Jan; 21():575-82. PubMed ID: 23567819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete Reconstitution of the Vancomycin-Intermediate Staphylococcus aureus Phenotype of Strain Mu50 in Vancomycin-Susceptible S. aureus.
    Katayama Y; Sekine M; Hishinuma T; Aiba Y; Hiramatsu K
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3730-42. PubMed ID: 27067329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneously vancomycin-intermediate Staphylococcus aureus (hVISA) emerged before the clinical introduction of vancomycin in Japan: a retrospective study.
    Yamakawa J; Aminaka M; Okuzumi K; Kobayashi H; Katayama Y; Kondo S; Nakamura A; Oguri T; Hori S; Cui L; Ito T; Jin J; Kurosawa H; Kaneko K; Hiramatsu K
    J Infect Chemother; 2012 Jun; 18(3):406-9. PubMed ID: 22033576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AgrA directly binds to the promoter of
    Liu X; Wang Y; Chang W; Dai Y; Ma X
    Antimicrob Agents Chemother; 2024 Mar; 68(3):e0089323. PubMed ID: 38259090
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevalence of vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous VISA among methicillin-resistant S. aureus with high vancomycin minimal inhibitory concentrations in Taiwan: A multicenter surveillance study, 2012-2013.
    Huang SH; Chen YC; Chuang YC; Chiu SK; Fung CP; Lu PL; Wang LS; Wu TL; Wang JT
    J Microbiol Immunol Infect; 2016 Oct; 49(5):701-707. PubMed ID: 26320398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VraSR and Virulence Trait Modulation during Daptomycin Resistance in Methicillin-Resistant
    Taglialegna A; Varela MC; Rosato RR; Rosato AE
    mSphere; 2019 Feb; 4(1):. PubMed ID: 30760612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacteremia.
    Howden BP; Johnson PD; Ward PB; Stinear TP; Davies JK
    Antimicrob Agents Chemother; 2006 Sep; 50(9):3039-47. PubMed ID: 16940100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CpG-ODN promotes phagocytosis and autophagy through JNK/P38 signal pathway in Staphylococcus aureus-stimulated macrophage.
    Wu HM; Wang J; Zhang B; Fang L; Xu K; Liu RY
    Life Sci; 2016 Sep; 161():51-9. PubMed ID: 27476088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vancomycin-intermediate Staphylococcus aureus isolates are attenuated for virulence when compared with susceptible progenitors.
    Cameron DR; Lin YH; Trouillet-Assant S; Tafani V; Kostoulias X; Mouhtouris E; Skinner N; Visvanathan K; Baines SL; Howden B; Monk IR; Laurent F; Stinear TP; Howden BP; Peleg AY
    Clin Microbiol Infect; 2017 Oct; 23(10):767-773. PubMed ID: 28396035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of vancomycin nonsusceptible strains in clinical isolates of Staphylococcus aureus in northern Iran.
    Asadpour L; Ghazanfari N
    Int Microbiol; 2019 Dec; 22(4):411-417. PubMed ID: 30811005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of selenium on the autophagy of macrophage infected by Staphylococcus aureus.
    Zang H; Qian S; Li J; Zhou Y; Zhu Q; Cui L; Meng X; Zhu G; Wang H
    Int Immunopharmacol; 2020 Jun; 83():106406. PubMed ID: 32193097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of telavancin against heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) in vitro and in an in vivo mouse model of bacteraemia.
    Hegde SS; Skinner R; Lewis SR; Krause KM; Blais J; Benton BM
    J Antimicrob Chemother; 2010 Apr; 65(4):725-8. PubMed ID: 20139142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel single-nucleotide variations associated with vancomycin resistance in vancomycin-intermediate
    Lin LC; Chang SC; Ge MC; Liu TP; Lu JJ
    Infect Drug Resist; 2018; 11():113-123. PubMed ID: 29403293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relevance of vancomycin-intermediate susceptibility and heteroresistance in methicillin-resistant Staphylococcus aureus bacteraemia.
    Khatib R; Jose J; Musta A; Sharma M; Fakih MG; Johnson LB; Riederer K; Shemes S
    J Antimicrob Chemother; 2011 Jul; 66(7):1594-9. PubMed ID: 21525024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of a globally disseminated hypervirulent clone, Staphylococcus aureus CC121, with reduced vancomycin susceptibility in community settings in China.
    Shen P; Zhou K; Wang Y; Song J; Liu Y; Zhou Y; Xiao Y
    J Antimicrob Chemother; 2019 Sep; 74(9):2537-2543. PubMed ID: 31203362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Slow-Growth Vancomycin Nonsusceptibility in Methicillin-Resistant Staphylococcus aureus.
    Katayama Y; Azechi T; Miyazaki M; Takata T; Sekine M; Matsui H; Hanaki H; Yahara K; Sasano H; Asakura K; Takaku T; Ochiai T; Komatsu N; Chambers HF
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28827421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.